Atlas Trials

SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT

Clinical trial NCT04387695 · UNKNOWN

Trial details

NCT number
NCT04387695
Sponsor
First Affiliated Hospital of Zhejiang University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Unresectable Hepatocellular CarcinomaPortal Vein Thrombosis
Start date
2020-04-30
Primary completion
2023-08-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.